News & Publications
Stay in the know about our company, science and our aspiration to use gene therapy to restore vision and prevent blindness.
News & Press Releases
News
February 27, 2023
News
January 18, 2023
News
December 6, 2022
News
November 10, 2022
Publications
Presentations
February 16, 2023
Presentations
February 11, 2023
Presentations
December 3, 2022
Presentations
November 4, 2022
Presentations
July 13, 2022
Investors
We’re pioneering innovation in the field of gene therapy. For our lead therapy ADVM-022, we are excited to see the potential for a single intravitreal injection to extend the treatment benefit from weeks to years in patients with wet AMD – even those who may have previously required frequent anti-VEGF injections. Our mission is to establish ocular gene therapy as a new standard of care for debilitating ocular diseases.
